Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Biomaterials. 2017 Mar 26;130:1–13. doi: 10.1016/j.biomaterials.2017.03.024

Table 1.

Quantification of hematological biomarkers of hepatic and renal toxicity as well as cytokine biomarkers of immunotoxicity.

Treatment AST (U/L) ALT (U/L) BUN (mg/dL) IL 6 (ng/mL) TNF-α (ng/mL)
Control 65 ± 10.3 34 ± 3.5 22 ± 0.6 1.1 ± 0.10 0.6 ± 0.11
G5/CEH 315 ± 114.9** 169 ± 81.8** 27 ± 6.1 3.6 ± 0.20** 0.7 ± 0.12
Gal-G5/CEH 71 ± 13.2 37 ± 8. 2 26 ± 5.6 1.6 ± 0.05 0.5 ± 0.05

Note: n=3,

**

P<0.01 vs. the control.